Analyst Price Target is $20.00
▲ +153.16% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Biofrontera in the last 3 months. The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00. The average price target represents a 153.16% upside from the last price of $7.90.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in Biofrontera.